Serveur d'exploration sur la grippe en Allemagne

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

[Influenza : clinical symptoms, diagnostics and therapy].

Identifieur interne : 000270 ( Main/Exploration ); précédent : 000269; suivant : 000271

[Influenza : clinical symptoms, diagnostics and therapy].

Auteurs : G G U. Rohde [Pays-Bas]

Source :

RBID : pubmed:21809066

Descripteurs français

English descriptors

Abstract

Influenza infections have important socio-economic consequences. Risk groups identified so far include small children and elderly adults with comorbidities. In recent years in addition to seasonal influenza an outbreak of avian influenza occurred in 2005 and the new H1N1 pandemic occurred in 2009. For the latter other at risk groups were affected and a different clinical course has been documented. The focus of this article is to give an overview on the epidemiology, clinical characteristics, diagnosis and therapy of influenza infections.

DOI: 10.1007/s00108-011-2859-7
PubMed: 21809066


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">[Influenza : clinical symptoms, diagnostics and therapy].</title>
<author>
<name sortKey="Rohde, G G U" sort="Rohde, G G U" uniqKey="Rohde G" first="G G U" last="Rohde">G G U. Rohde</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Respiratory Medicine, University Medical Center Maastricht, Netherlands. g.rohde@mumc.nl</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Respiratory Medicine, University Medical Center Maastricht</wicri:regionArea>
<wicri:noRegion>University Medical Center Maastricht</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21809066</idno>
<idno type="pmid">21809066</idno>
<idno type="doi">10.1007/s00108-011-2859-7</idno>
<idno type="wicri:Area/Main/Corpus">000274</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000274</idno>
<idno type="wicri:Area/Main/Curation">000274</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000274</idno>
<idno type="wicri:Area/Main/Exploration">000274</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">[Influenza : clinical symptoms, diagnostics and therapy].</title>
<author>
<name sortKey="Rohde, G G U" sort="Rohde, G G U" uniqKey="Rohde G" first="G G U" last="Rohde">G G U. Rohde</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Respiratory Medicine, University Medical Center Maastricht, Netherlands. g.rohde@mumc.nl</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Respiratory Medicine, University Medical Center Maastricht</wicri:regionArea>
<wicri:noRegion>University Medical Center Maastricht</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Der Internist</title>
<idno type="eISSN">1432-1289</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>AIDS-Related Opportunistic Infections (diagnosis)</term>
<term>AIDS-Related Opportunistic Infections (mortality)</term>
<term>AIDS-Related Opportunistic Infections (therapy)</term>
<term>Adamantane (therapeutic use)</term>
<term>Adult (MeSH)</term>
<term>Age Factors (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>Female (MeSH)</term>
<term>Germany (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Infant (MeSH)</term>
<term>Influenza A Virus, H1N1 Subtype (MeSH)</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza, Human (diagnosis)</term>
<term>Influenza, Human (mortality)</term>
<term>Influenza, Human (therapy)</term>
<term>Male (MeSH)</term>
<term>Neuraminidase (antagonists & inhibitors)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (diagnosis)</term>
<term>Pneumonia, Viral (mortality)</term>
<term>Pneumonia, Viral (therapy)</term>
<term>Population Surveillance (MeSH)</term>
<term>Pregnancy (MeSH)</term>
<term>Rimantadine (therapeutic use)</term>
<term>Survival Rate (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adamantane (usage thérapeutique)</term>
<term>Adulte (MeSH)</term>
<term>Allemagne (MeSH)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Enfant (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Facteurs âges (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (diagnostic)</term>
<term>Grippe humaine (mortalité)</term>
<term>Grippe humaine (thérapie)</term>
<term>Grossesse (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections opportunistes liées au SIDA (diagnostic)</term>
<term>Infections opportunistes liées au SIDA (mortalité)</term>
<term>Infections opportunistes liées au SIDA (thérapie)</term>
<term>Mâle (MeSH)</term>
<term>Nourrisson (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (diagnostic)</term>
<term>Pneumopathie virale (mortalité)</term>
<term>Pneumopathie virale (thérapie)</term>
<term>Rimantadine (usage thérapeutique)</term>
<term>Sialidase (antagonistes et inhibiteurs)</term>
<term>Sous-type H1N1 du virus de la grippe A (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Surveillance de la population (MeSH)</term>
<term>Taux de survie (MeSH)</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Neuraminidase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Adamantane</term>
<term>Antiviral Agents</term>
<term>Rimantadine</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Germany</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Sialidase</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>AIDS-Related Opportunistic Infections</term>
<term>Influenza, Human</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Grippe humaine</term>
<term>Infections opportunistes liées au SIDA</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en">
<term>AIDS-Related Opportunistic Infections</term>
<term>Influenza, Human</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr">
<term>Grippe humaine</term>
<term>Infections opportunistes liées au SIDA</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>AIDS-Related Opportunistic Infections</term>
<term>Influenza, Human</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr">
<term>Grippe humaine</term>
<term>Infections opportunistes liées au SIDA</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Adamantane</term>
<term>Antiviraux</term>
<term>Rimantadine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Male</term>
<term>Pandemics</term>
<term>Population Surveillance</term>
<term>Pregnancy</term>
<term>Survival Rate</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Allemagne</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Facteurs âges</term>
<term>Femelle</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Pandémies</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sujet âgé</term>
<term>Surveillance de la population</term>
<term>Taux de survie</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Allemagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Influenza infections have important socio-economic consequences. Risk groups identified so far include small children and elderly adults with comorbidities. In recent years in addition to seasonal influenza an outbreak of avian influenza occurred in 2005 and the new H1N1 pandemic occurred in 2009. For the latter other at risk groups were affected and a different clinical course has been documented. The focus of this article is to give an overview on the epidemiology, clinical characteristics, diagnosis and therapy of influenza infections.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">21809066</PMID>
<DateCompleted>
<Year>2012</Year>
<Month>02</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>05</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1432-1289</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>52</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2011</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Der Internist</Title>
<ISOAbbreviation>Internist (Berl)</ISOAbbreviation>
</Journal>
<ArticleTitle>[Influenza : clinical symptoms, diagnostics and therapy].</ArticleTitle>
<Pagination>
<MedlinePgn>1047-52</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s00108-011-2859-7</ELocationID>
<Abstract>
<AbstractText>Influenza infections have important socio-economic consequences. Risk groups identified so far include small children and elderly adults with comorbidities. In recent years in addition to seasonal influenza an outbreak of avian influenza occurred in 2005 and the new H1N1 pandemic occurred in 2009. For the latter other at risk groups were affected and a different clinical course has been documented. The focus of this article is to give an overview on the epidemiology, clinical characteristics, diagnosis and therapy of influenza infections.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rohde</LastName>
<ForeName>G G U</ForeName>
<Initials>GG</Initials>
<AffiliationInfo>
<Affiliation>Department of Respiratory Medicine, University Medical Center Maastricht, Netherlands. g.rohde@mumc.nl</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Influenza : Klinische Symptome, Diagnostik und Therapie.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Internist (Berl)</MedlineTA>
<NlmUniqueID>0264620</NlmUniqueID>
<ISSNLinking>0020-9554</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0T2EF4JQTU</RegistryNumber>
<NameOfSubstance UI="D012299">Rimantadine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.2.1.18</RegistryNumber>
<NameOfSubstance UI="D009439">Neuraminidase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>PJY633525U</RegistryNumber>
<NameOfSubstance UI="D000218">Adamantane</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D017088" MajorTopicYN="N">AIDS-Related Opportunistic Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000218" MajorTopicYN="N">Adamantane</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009439" MajorTopicYN="N">Neuraminidase</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012299" MajorTopicYN="N">Rimantadine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>8</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>8</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2012</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21809066</ArticleId>
<ArticleId IdType="doi">10.1007/s00108-011-2859-7</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2010 Feb;85(2):381-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19917319</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2001 Feb;20(2):127-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11224828</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pneumologie. 2009 Jan;63(1):14-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19137502</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drugs. 2004;64(18):2031-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15341496</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2011 May 19;11:134</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21592407</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Infect. 2010 Sep;16(9):1358-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21382125</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Avian Dis. 2007 Mar;51(1 Suppl):194-200</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17494553</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2000 May;19(5):410-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10819336</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2011 Jan 1;203(1):13-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21148491</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2000 Feb 23;283(8):1016-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10697061</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2009 Oct;83(20):10366-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19641000</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2006 Jun 15;193(12):1626-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16703504</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thorax. 2009 Jul;64(7):567-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19321465</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2004 Aug;73(4):617-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15221909</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2009 Dec 08;339:b5106</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19995812</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thorax. 2003 Jan;58(1):37-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12511718</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2009 May;47(5):1372-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19321726</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infection. 2009 Jun;37(3):186-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19471854</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Top Microbiol Immunol. 2009;333:413-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19768417</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chest. 1997 Sep;112(3):591-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9315789</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mayo Clin Proc. 2010 Jan;85(1):64-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20007905</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2006 Feb 22;295(8):891-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16456087</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Respir J. 2011 Jul;38(1):147-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21148226</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2005 Sep 29;353(13):1363-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16192481</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CMAJ. 2003 Jan 7;168(1):49-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12515786</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2009 Dec 08;339:b5164</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19995813</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2000 Jan 27;342(4):232-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10648764</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 1998 Dec 12;352(9144):1877-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9863784</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2006 Jan 28;367(9507):303-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16443037</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatrics. 2008 Jan;121(1):1-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18166550</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2010 May;86(2):128-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20083142</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dtsch Med Wochenschr. 2011 Apr;136(15):775-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21469047</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pneumologie. 2010 Jan;64(1):18-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20091441</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cochrane Database Syst Rev. 2010 Jul 07;(7):CD001269</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20614424</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2007 Jan;7(1):21-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17182341</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2005 Oct 1;366(9492):1175-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16198766</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antivir Ther. 2007;12(4):571-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17668567</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2004 Sep 15;292(11):1333-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15367555</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2005 Sep 8;437(7056):209-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16079797</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Med. 2008;59:397-413</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17939760</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Respir J. 2011 Jul;38(1):106-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21109555</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Allergy. 2011 Jan;66(1):25-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20716316</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cochrane Database Syst Rev. 2010 Feb 17;(2):CD001265</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20166059</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2008 Jan;77(1):72-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17897729</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2009 Dec 11;58(48):1351-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20010511</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000364</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18425863</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Respir J. 2009 Jul;34(1):56-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19213779</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2000 Jan 27;342(4):225-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10648763</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 Nov 22;362(9397):1733-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14643124</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2003 Jul 28;163(14):1667-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12885681</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2004 Aug 28-Sep 3;364(9436):759-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15337401</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2006 Nov 23;355(21):2174-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17124014</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Wkly Epidemiol Rec. 2011 Mar 4;86(10):86-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21395187</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2005 Mar 18;23(17-18):2251-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15755605</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Geriatr Soc. 2001 Aug;49(8):1025-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11555062</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatrics. 2011 Jul;128(1):e27-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21646257</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Mar 5;360(10):953-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19258250</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2009 Dec 08;339:b5351</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19995815</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 1997 Sep 25;337(13):874-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9302301</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2009 Nov 5;27 Suppl 4:D65-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19837290</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002733</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16437444</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Pays-Bas</li>
</country>
</list>
<tree>
<country name="Pays-Bas">
<noRegion>
<name sortKey="Rohde, G G U" sort="Rohde, G G U" uniqKey="Rohde G" first="G G U" last="Rohde">G G U. Rohde</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeAllemagneV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000270 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000270 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeAllemagneV4
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21809066
   |texte=   [Influenza : clinical symptoms, diagnostics and therapy].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21809066" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeAllemagneV4 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Mon Aug 10 17:53:30 2020. Site generation: Sat Mar 27 17:40:37 2021